A roadmap for MERS-CoV research and product development

report from a World Health Organization consultation

Overview

As part of the World Health Organization (WHO) R&D Blueprint initiative, leading stakeholders on Middle East respiratory syndrome coronavirus (MERS-CoV) convened to agree on strategic public-health goals and global priority research activities that are needed to combat MERS-CoV.

WHO Team
Immunization, Vaccines and Biologicals (IVB)